Skip to main content

Table 1 Study population (before matching)

From: Cost and effectiveness of prescribing emollient therapy for atopic eczema in UK primary care in children and adults: a large retrospective analysis of the Clinical Practice Research Datalink

 

Emollient

(n = 45,218)

Non-Emollient

(n = 9780)

Regional distribution %

 East Midlands

8.91

10.55

 London

12.5

8.67

 North East

1.75

3.13

 North West

11.87

14.66

 Northern Ireland

3.7

1.51

 Scotland

10.79

9.62

 South Central

11.62

13.15

 South East Coast

7.95

11.13

 South West

7.2

8.26

 Wales

12.36

6.56

 West Midlands

9.43

10.47

 Yorkshire and Humber

1.92

2.27

Age distribution %

 Less than 1 year

13.43

1.17

 1 to 5 years

29.24

6.13

 6 to 10 years

7.1

3.21

 11 to 15 years

5.64

3.64

 16 to 18 years

2.87

2.32

 19 to 65 years

26.38

63.11

 More than 65 years

15.33

20.42

Disease type %

 Atopic dermatitis/eczema

43.62

26.24

 Contact dermatitis

2.8

6.95

 Dermatitis NOS

6.31

14.39

 Dermatitis/dermatoses

1.49

2.84

 Eczema NOS

18.36

15.12

 Flexural eczema

3.37

1.44

 Hand eczema

1.04

1.29

 Infantile eczema

13.84

1.55

 Infected eczema

2.57

4.54

 Itch

2.06

7.46

 Pruritus NOS

3.28

9.71

 Seborrhoeic dermatitis capitis

0.45

5.62

 Skin irritation

0.81

2.85

  1. Note that responses from 1451 subjects for Disease Type were missing and not included in this analysis
  2. NOS, not otherwise specified